Literature DB >> 2159425

Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase.

V Knäuper1, H Reinke, H Tschesche.   

Abstract

Highly purified human polymorphonuclear leucocyte collagenase cleaved human alpha-1-proteinase inhibitor (alpha 1-PI) at the carboxyl site of Phe352 (P7). The inhibitor was thereby rapidly inactivated and generated a primary degradation product as shown by reverse-phase HPLC and N-terminal sequencing. Prolonged incubation of the modified inhibitor with polymorphonuclear leucocyte collagenase led to the generation of a secondary degradation product with additional cleavage at the carboxyl site of Pro357 (P2).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159425     DOI: 10.1016/0014-5793(90)81412-h

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Evolutionary families of peptidase inhibitors.

Authors:  Neil D Rawlings; Dominic P Tolle; Alan J Barrett
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

3.  Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity.

Authors:  P E Desrochers; J J Jeffrey; S J Weiss
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma.

Authors:  K Bangert; A H Johnsen; U Christensen; S Thorsen
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

Review 5.  Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.

Authors:  O Guttman; B M Baranovski; R Schuster; Z Kaner; G S Freixo-Lima; N Bahar; N Kalay; M I Mizrahi; I Brami; D E Ochayon; E C Lewis
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

6.  Fragmentation of human polymorphonuclear-leucocyte collagenase.

Authors:  V Knäuper; A Osthues; Y A DeClerck; K E Langley; J Bläser; H Tschesche
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

7.  Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.

Authors:  E Eldering; C C Huijbregts; J H Nuijens; A J Verhoeven; C E Hack
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

8.  Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase.

Authors:  T Sorsa; O Lindy; Y T Konttinen; K Suomalainen; T Ingman; H Saari; S Halinen; H M Lee; L M Golub; J Hall
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.

Authors:  Julie Decock; Wouter Hendrickx; Sally Thirkettle; Ana Gutiérrez-Fernández; Stephen D Robinson; Dylan R Edwards
Journal:  Breast Cancer Res       Date:  2015-03-14       Impact factor: 6.466

10.  Network analyses reveal pervasive functional regulation between proteases in the human protease web.

Authors:  Nikolaus Fortelny; Jennifer H Cox; Reinhild Kappelhoff; Amanda E Starr; Philipp F Lange; Paul Pavlidis; Christopher M Overall
Journal:  PLoS Biol       Date:  2014-05-27       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.